These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38083)

  • 1. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
    Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
    Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry.
    Lynn RK; Smith RG; Thompson RM; Deinzer ML; Griffin D; Gerber N
    Drug Metab Dispos; 1978; 6(4):494-501. PubMed ID: 28932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Butler TC; Dudley KH
    Drug Metab Dispos; 1982; 10(6):595-8. PubMed ID: 6130906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mephenytoin metabolites in the dog.
    Karlaganis G; Küpfer A; Bircher J; Schlunegger UP; Gfeller H; Bigler P
    Drug Metab Dispos; 1980; 8(3):173-7. PubMed ID: 6104582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the epoxide-diol pathway in the biotransformation of mephenytoin.
    Gerber N; Thompson RM; Smith RG; Lynn RK
    Epilepsia; 1979 Jun; 20(3):287-94. PubMed ID: 446437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
    Bius DL; Yonekawa WD; Kupferberg HJ; Cantor F; Dudley KH
    Drug Metab Dispos; 1980; 8(4):223-9. PubMed ID: 6105055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization.
    Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM
    Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
    Bernauer U; Amberg A; Scheutzow D; Dekant W
    Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
    Thompson RM; Beghin J; Fife WK; Gerber N
    Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
    Kwok DW; McErlane KM; Axelson JE
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):395-409. PubMed ID: 2111573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of methoxyphenamine in man and in monkey.
    Midha KK; Cooper JK; Mcgilveray IJ; Coutts RT; Dawe R
    Drug Metab Dispos; 1976; 4(6):568-76. PubMed ID: 11979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of tripelennamine in man.
    Chaudhuri NK; Servando OA; Manniello MJ; Luders RC; Chao DK; Bartlett MF
    Drug Metab Dispos; 1976; 4(4):372-8. PubMed ID: 8293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human metabolism of cyproheptadine.
    Porter CC; Arison BH; Gruber VF; Titus DC; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(3):189-97. PubMed ID: 238818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of mephenytoin (3-methyl-5-ethyl-5-phenylhydantoin) and its demethylated metabolite by selective ion monitoring.
    Yonekawa W; Kupferberg HJ
    J Chromatogr; 1979 Jun; 163(2):161-7. PubMed ID: 541367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric analysis of cyclofenil and its metabolites in human urine.
    Myung SW; Min HK; Kim DH; Kim M; Cha S; Yoo EA; Yim YH
    Rapid Commun Mass Spectrom; 2002; 16(8):761-7. PubMed ID: 11921260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.
    Maggs JL; Pirmohamed M; Kitteringham NR; Park BK
    Drug Metab Dispos; 1997 Mar; 25(3):275-80. PubMed ID: 9172943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.
    Dumasia MC
    Rapid Commun Mass Spectrom; 2003; 17(4):320-9. PubMed ID: 12569442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.